Focus Diagnostics gets FDA clearance for H1N1 flu test

05/24/2010 | United Press International

The FDA has cleared Focus Diagnostics' Simplexa Influenza A H1N1 (2009) virus test, which can spot the virus in samples from nasal swabs or nasal aspirates. "With this clearance, the availability of Simplexa H1N1 test will not be affected when the public health emergency expires," said Dr. Jeffrey Shuren, director of the agency's Center for Devices and Radiological Health.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY